Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05082090

A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

This protocol is designed to study Orthofix regulatory approved and commercially available spine devices to generate Real World Evidence (RWE) of device safety and performance in the treatment of patients with spine injuries and/or disorders following the local medical standard of care. The clinical data generated from this study will support compliance to global regulatory requirements including but not limited to the European Medical Device Regulation (EU MDR) for the applicable devices.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Spinal Disorders/Injuries Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Marien-Krankenhaus Bergisch Gladbach, Bergisch Gladbach, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient diagnosed with a spine injury/disorder and undergoing or has undergone spine procedure at the participating investigative centers utilizing Orthofix Spine devices.
  • Patient is 18 years or older at the time of surgery.
  • Patient is capable of understanding the content of the patient information / Informed Consent Form (ICF) for the prospective segment of the study.
  • Patient is willing and able to participate in the prospective data collection protocol and comply with the required data collection.

Note: For retrospective segment of the study: A waiver of consent for retrospective data collection is in place OR an informed consent is obtained from the participating patient prior to data collection as required by local regulations.

Exclusion criteria

  • Patient may be excluded from study participation if there are other concurrent medical or other conditions (chronic or acute in nature) that in the opinion of the participating investigator may prevent participation or otherwise render patient ineligible for the study.

Treatment and study plan

spinal surgery

Procedure

Implanted with Orthofix Spinal products

Primary outcomes

  1. Primary Safety Assessment: Device or procedure related adverse events

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Evaluation of device related or procedure related adverse events

  2. Primary Effectiveness Assessments: Fusion status measured radiographs

    Time frame: Intra-operative to up to 10-years Post-Operative

    Fusion status measured utilizing quantitative and qualitative radiographic assessments as applicable

  3. Primary Effectiveness Assessment

    Time frame: Intra-operative to up to 10-years Post-Operative

    Improvement in pain measured with Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS): NRS is an 11-point scale for patient self-reporting of pain. Patients rate their current pain intensity at the time of the visit from 0 ("no pain") to 10 ("worst possible pain") by selecting a number on a horizontal bar. NRS scores for the evaluation of pain have been categorized as mild (1-3), moderate (4-6), or severe (7-10). VAS scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

  4. Primary Effectiveness Assessment

    Time frame: Intra-operative to up to 10-years Post-Operative

    Improvement in function as measured with Neck Disability Index (NDI) or Oswestry Disability Index (ODI).

    NDI includes 4 items that relate to subjective symptomatology (pain severity, headache, concentration, sleeping) and 6 items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading). Each item is scored from 0 to 5, with higher scores corresponding to greater disability. A total NDI score is determined by adding the scores of the individual questions and dividing that total by the maximum possible score (i.e., 50 if all questions are answered) to yield a percentage. Therefore, the NDI score ranges from 0 to 100. The ODI was developed as a specific outcomes tool for subjects suffering from back pain. The questionnaire scores 10 aspects of the subject's home and work life and analgesic use. The disability index is then calculated as a percentage with a high percentage indicating a high level of disability.

Secondary outcomes

  1. Secondary Safety Assessments: Additional required medical treatments and/or supplemental surgical procedure

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Additional required medical treatments and/or supplemental surgical procedure(s) at the index level (including revision, removal, reoperation, or supplemental fixation).

    Percentage of patients that required additional/supplemental treatments and/or surgical procedures and time to additional surgery.

  2. Secondary Effectiveness Assessments: Quality of Life assessment

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Quality of Life score measured utilizing PROMIS-29 PROMIS®-29 Profile v2. PROMIS (Patient-Reported Outcomes Measurement Information System) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This instrument is comprised of 8 constructs: Physical Function; Anxiety; Depression; Fatigue; Sleep Disturbance; Ability to Participate in Social Roles and Activities; Pain Interference; and Pain Intensity that closely evaluate the impact of a patient's health on their quality of life

  3. Secondary Effectiveness Assessments: Changes in neurological function

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Maintenance or improvement in neurological function Neurological function will be evaluated, where neurological examination is performed as part of standard of care. The outcome of neurological function assessment (normal versus abnormal) and details related to abnormal sensory function (i.e. absent/impaired/normal/other) will be collected as appropriate.

  4. Secondary Effectiveness Assessments: Work and Activity status

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Work/Activity status

    Return to Work: The ability to and the time it takes for the subjects to return to work from the date of surgery will be documented.

    Return to Normal/Usual activities: The ability to and the time it takes for the subjects to return to normal daily activities from the date of surgery will be documented.

  5. Secondary Effectiveness Assessments: Patient Satisfaction

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Patient satisfaction At ≥ 6-months after the index procedure, subjects will be asked how satisfied they are with the results of their surgery on a 5-point Likert Scale (Very Satisfied; Satisfied; Neutral; Unsatisfied; Very Unsatisfied).

  6. Secondary Effectiveness Assessments: Duration of Surgery

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Surgery time

  7. Secondary Effectiveness Assessments: Duration of Hospital stay

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Length of hospital stay

  8. Secondary Safety Assessments: Device and/or procedure-related deficiencies

    Time frame: Pre-Operative to up to 10-years Post-Operative

    Quantitative and qualitative radiographic assessments for evidence of device and/or procedure-related deficiencies.

    Inadequacy of a medical device with respect to its identity, quality, durability, reliability, usability, safety or performance will be documented. Percentage of patients with device deficiency will be reported

Sponsors and collaborators

Lead sponsor

Orthofix Inc.

Industry

Registry information

Acronym: RWE Spine

Important dates

Study start
2021
Primary completion
2031
Study completion
2031
First posted
Oct 18, 2021
Registry last updated
Jul 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.